Neuronetics Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 4/6
Neuronetics has a total shareholder equity of $19.4M and total debt of $59.8M, which brings its debt-to-equity ratio to 308.3%. Its total assets and total liabilities are $96.8M and $77.4M respectively.
Anahtar bilgiler
308.3%
Borç/özkaynak oranı
US$59.76m
Borç
| Faiz karşılama oranı | n/a |
| Nakit | US$42.64m |
| Eşitlik | US$19.39m |
| Toplam yükümlülükler | US$77.43m |
| Toplam varlıklar | US$96.81m |
Son finansal sağlık güncellemeleri
Neuronetics (NASDAQ:STIM) Has Debt But No Earnings; Should You Worry?
May 01
Does Neuronetics (NASDAQ:STIM) Have A Healthy Balance Sheet?
May 10Is Neuronetics (NASDAQ:STIM) Using Debt Sensibly?
Sep 06Is Neuronetics (NASDAQ:STIM) A Risky Investment?
Jun 08Recent updates
Investors Give Neuronetics, Inc. (NASDAQ:STIM) Shares A 60% Hiding
Aug 13Here's Why Shareholders May Want To Be Cautious With Increasing Neuronetics, Inc.'s (NASDAQ:STIM) CEO Pay Packet
May 24The Neuronetics, Inc. (NASDAQ:STIM) First-Quarter Results Are Out And Analysts Have Published New Forecasts
May 09Neuronetics: Reality Set In
May 09Market Cool On Neuronetics, Inc.'s (NASDAQ:STIM) Revenues Pushing Shares 36% Lower
May 08Neuronetics (NASDAQ:STIM) Has Debt But No Earnings; Should You Worry?
May 01Even With A 26% Surge, Cautious Investors Are Not Rewarding Neuronetics, Inc.'s (NASDAQ:STIM) Performance Completely
Mar 17Neuronetics: Modest Improvements Are Not Enough
Jan 30Neuronetics, Inc. (NASDAQ:STIM) Soars 61% But It's A Story Of Risk Vs Reward
Dec 19Neuronetics, Inc.'s (NASDAQ:STIM) Shares Not Telling The Full Story
Jun 21Does Neuronetics (NASDAQ:STIM) Have A Healthy Balance Sheet?
May 10Neuronetics: Growth To Capture, But Fairly Priced
Sep 06Is Neuronetics (NASDAQ:STIM) Using Debt Sensibly?
Sep 06Neuronetics gets FDA nod for its D-Tect accessory product for use to treat depression
Aug 29Neuronetics GAAP EPS of -$0.39 beats by $0.02, revenue of $16.3M beats by $0.84M , revises FY guidance
Aug 02Neuronetics stock soars 30% as FDA clears NeuroStar system for anxious depression
Jul 19Is Neuronetics (NASDAQ:STIM) A Risky Investment?
Jun 08Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: STIM's short term assets ($75.5M) exceed its short term liabilities ($29.3M).
Uzun Vadeli Yükümlülükler: STIM's short term assets ($75.5M) exceed its long term liabilities ($48.2M).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: STIM's net debt to equity ratio (88.3%) is considered high.
Borcun Azaltılması: STIM's debt to equity ratio has increased from 51.4% to 308.3% over the past 5 years.
Bilanço
Nakit Pist Analizi
Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.
İstikrarlı Nakit Pisti: STIM has sufficient cash runway for more than a year based on its current free cash flow.
Tahmini Nakit Akışı: STIM has sufficient cash runway for 1.4 years if free cash flow continues to reduce at historical rates of 7.4% each year.